论文部分内容阅读
目的探讨血浆脑钠肽(BNP)水平在非糖尿病急性心肌梗死合并应激性高血糖患者病情评估中的作用。方法对广东省清远市中医院收治的102例AMI患者检测血浆BNP浓度,并对结果进行回顾性分析。结果①发病后24血浆BNP水平在非糖尿病AMI合并应激性高血糖组结果(1713.6±687.03)ng/L,明显高于未合并应激性高血糖组,P<0.01;②试验组与对照组恶性心律失常、心力衰竭、心源性休克发生率比较差异均有统计学意义(P<0.05)。结论血浆BNP的水平可以判断非糖尿病AMI合并应激性高血糖患者病情危重程度,血浆BNP可作为判断非糖尿病AMI合并应激性高血糖患者危险性指标。
Objective To investigate the role of plasma brain natriuretic peptide (BNP) in the evaluation of the condition of patients with non-diabetic acute myocardial infarction complicated by stress hyperglycemia. Methods Plasma BNP levels were measured in 102 AMI patients admitted to Qingyuan Hospital of Traditional Chinese Medicine in Guangdong Province. The results were retrospectively analyzed. Results ① After the onset of stroke, plasma BNP levels in non-diabetic AMI patients with stress hyperglycemia (1713.6 ± 687.03) ng / L were significantly higher than those in patients without stress hyperglycemia (P <0.01). ② Compared with control group, The incidence of malignant arrhythmia, heart failure and cardiogenic shock were statistically significant (P <0.05). Conclusions Plasma BNP levels can be used to determine the severity of non-diabetic AMI patients with stress hyperglycemia, and plasma BNP can be used as a risk index for judging non-diabetic AMI patients with stress hyperglycemia.